Literature DB >> 35261016

Factors associated with acute and recurrent erysipelas in a young population: a retrospective of 147 cases.

Amal Chamli, Kahena Jaber, Imene Ben Lagha, Malek Ben Slimane, Faten Rabhi, Nejib Doss, Mohamed Raouf Dhaoui.   

Abstract

BACKGROUND: erysipelas is a common infection of the superficial layer of the skin, predominantly caused by groups A β-hemolytic streptococci. It is an acute infection of the skin and frequently affects the legs. It is common in the elderly and favoured by the associated comorbidities. Its occurrence in young healthy people is rare. AIM: The present study aimed to elucidate factors associated with acute and recurrent erysipelas in a young population.
METHODS: We retrospectively analyzed 147 cases of erysipelas admitted to the dermatology department of the Military Hospital of Tunis, Tunisia, over 18 years, identifying factors associated with recurrence. All patients were aged less than 35 years.
RESULTS: During the study period, 147 patients were registered with the diagnosis of erysipelas. There were 125 military soldiers and 22 non-military patients. The prevalence of erysipelas was 2.23%. The median age was 25 years. Almost 86.2% of patients were male. The main favorable factors were: obesity (9%), alcoholism (8%), chronic venous insufficiency (6.5%), chronic lymphedema (3%), leg fracture (2%), and diabetes mellitus (1%). The lesions were mostly located in the lower limbs in 94.9%. According to our multivariate analysis, there was an association between recurrence and diabetes mellitus (p=0.02), female sex (p=0.004), onychomycosis (p=0.004), and plantar dyshidrotic eczema (p<0.005).
CONCLUSION: Identifying factors associated with recurrent erysipelas in a young population remains essential for proposing primary and secondary prevention measures.

Entities:  

Mesh:

Year:  2021        PMID: 35261016      PMCID: PMC9003589     

Source DB:  PubMed          Journal:  Tunis Med        ISSN: 0041-4131


Introduction

Acute bacterial non necrotizing erysipelas is a common infection of the superficial layer of the skin, predominantly caused by groups A β-hemolytic streptococci. It is an acute infection of the skin and frequently affects the legs 1 . Previous studies showed an increase in the incidence of erysipelas 2 . Clinically, this condition is characterized by the acute onset of a well-demarcated erythematous plaque, edema, local hardening, and pain. Systemic manifestations such as fever, regional lymphadenopathy, may also be present. Erysipelas usually affects elderly patients or patients with predisposing factors. The most distressing complication is recurrence. For initial episodes, risk factors have been well documented. The disease is associated with chronic lymphedema and venous insufficiency, obesity, cardiovascular diseases, diabetes mellitus, and alcohol abuse (3, 4 ). Although risk factors for the initial episode and recurrence have been well defined, factors associated with recurrence in a young population have not been evaluated to date. The present study aimed to elucidate factors associated with acute and recurrent erysipelas in a young population.

Methods

We enrolled a retrospective study in the dermatology department of the Military Hospital of Tunis, Tunisia, between January 2000 and December 2017. In total, 147 patients, less than 35 years and hospitalized for erysipelas, were included. Erysipelas was defined as a skin infection of sudden onset with a well-demarcated erythematous plaque which can be associated with fever or a satellite node lymphadenopathy. Obesity was defined as body mass index (BMI) ≥30. The following parameters of each hospitalization were analyzed: gender, age, BMI, length of hospital stay, the period of the year, and the main comorbidities (cardiovascular diseases, diabetes mellitus, chronic venous insufficiency, chronic lymphedema, local operation, radiation therapy, and wound surgical interventions at the area affected by erysipelas), alcohol abuse, local factors (defined as a disruption of the cutaneous barrier), localization, recurrent episodes, treatment, complications, and prophylactic measures taken. The Fisher exact test, chi-squared tests, and logistic regression were used for statistical analysis. A P value <0.05 was considered statistically significant. All analysis was performed with SPSS (version 23 for windows).

Results

Patient demographics

During the study period, 147 patients were registered with the diagnosis of erysipelas. There were 125 military soldiers and 22 non-military patients. The prevalence of erysipelas was 2.23%. The median age was 25 years. Almost 86.2% of patients were male. The mean body mass index (BMI) was 25.4 ± 7.33 kg/m2. The main favorable factors were: obesity (9%), alcoholism (8%), chronic venous insufficiency (6.5%), chronic lymphedema (3%), leg fracture (2%), and diabetes mellitus (1%). The lesions were mostly located in the lower limbs in 94.9%, in the upper limbs in 4.3%, and on the buttocks in 0.7%. A summer-autumn recrudescence was noted, 58.5% of patients consulted from July to October. Recurrent erysipelas was diagnosed in 13.6% of patients.

Clinical presentation and severity

Erysipelas was associated with fever in 38.4% of cases, satellite lymphadeno pathy in 31.15%, and lymphangitis in 4.3%. The most frequent portal entries were: toe-web intertrigo in 47.8% and neglected traumatic wound in 19.5%. Local signs of severity as bullae and purpura were found in 12.3% of cases. Complications were: abscess 7.2% of patients and thrombosis in 0.7% of patients. Nonsteroidal anti-inflammatory drug-taking was significantly associated with severe erysipelas in univariate and multivariate analysis. The first-line therapy was intravenous Penicillin G in 68.1% of cases. The mean hospital stay was 14±3 days. Prophylactic treatment was prescribed in 5.8% of patients.

Associatedfactors for recurrenterysipelas

Table 1 shows the results of univariate analysis of patient demographics, and general and local factors studied. According to our multivariate analysis, there was an association between recurrence and diabetes mellitus (p=0.02), female sex (p=0.004), onychomycosis (p=0.004), and plantar dyshidrotic eczema (p<0.005) (Table 2 ).

Table 1 : Univariate analysis of favorable factors for recurrent erysipelas

Favorable factors

with recurrence (n=6)

Without recurrence (n=141)

Odds Ratio

IC 95%

P value

-sex (Male/Female)

3/3

124/17

7,29

1,36-39,08

0,033

-Diabetes mellitus

1 (16,7%)

1 (0,8%)

28

1,52-514,92

NS

-BMI

30 Kg/m2

25 Kg/m2

7,33

24-26,8

NS

-lymphedema

1 (16,7%)

4 (3,1%)

6,87

0,64-72,98

NS

-venous insufficiency

1 (16,7%)

6 (4,3%)

4,5

0,45-44,7

NS

-Alcoholism

1 (16,7%)

9 (6,9%)

2,71

0,28-25,75

NS

-Local signs of severity

1 (25%)

6 (42,9%)

0,44

0,03-5,4

NS

-Toe-web intretrigo

3 (50%)

63 (44,7%)

1,23

0,24-6,34

NS

-Traumatic wound

0

30 (21,3%)

NS

-Cutaneous leishmaniasis

0

12 (8,5%)

NS

-Plantar dyshidrosis eczema

2 (33,3%)

4 (2,8%)

17,12

2,39-122,44

0,019

-Insect bite

0

7 (5%)

NS

-Onychomycosis

1 (16,7%)

2 (1,4%)

13,9

1,07-179,96

NS

Percents are given in parentheses, NS: non significant

Table 2: Multivariate analysis offavorable factors for recurrent erysipelas

Factors associated with of recurrent erysipelas

P value

Female

0,042

Plantar dyshidrosis eczema

<10-3

Diabetes mellitus

0,002

Onychomycosis

0,004

Discussion

Factors associated with recurrent erysipelas in the youth have not been determinate in the literature. We analyzed 147 cases of erysipelas admitted to our dermatology department over 18 years, identifying factors associated with recurrence in a military hospital. All patients were aged less than 35 years. Erysipelas is not a rare infection in a young healthy population, the prevalence in our study was 2.23%. The main favorable factors were both local and general: obesity, alcoholism, chronic venous insufficiency, chronic lymphedema, leg fracture, and diabetes mellitus. Besides, we found that onychomycosis, diabetes mellitus, female sex, and plantar dyshidrosis eczema were significantly associated with recurrence. The use of anti-inflammatory agents was frequent and significantly associated with severe signs. As in previous case-control studies, general factors do not represent major risk factors in erysipelas. Local factors are potential risks for erysipelas. It is known that lymphedema, venous insufficiency, and toe-web intertrigo are risk factors for erysipelas (3, 5 ). In the literature, the most frequently reported favorable factors for recurrence are: age, female sex, diabetes mellitus, lymphedema, and venous insufficiency (6, 7, 8 ). It has been suggested that lymphedema is strongly associated with recurrence (6 ,9, 10, 11 ). In our patients, lymphedema was a very important factor for recurrence but not significantly different than patients without recurrence. The results in our series were different from the literature given the difference in the studied population. In fact, the most prominent associate factors for recurrence in our study were plantar dyshidrotic eczema, followed by diabetes mellitus, onychomycosis and female sex. In fact, 85% of our patients were soldiers. Indeed, this population presents particular favorable factors as wearing occlusive shoes for a long time, long-standing, care access, and activities exposing to repeated trauma neglected by soldiers can be also incriminated 12 . Then, they can develop plantar dyshidrosis eczema, toe-web intertrigo, and venous insufficiency. Although recurrent erysipelas is not a rare infection in a young population, factors associated with recurrence have not been elucidated in the literature. Moreover, favorable factors for recurrence are not the same in the elderly than the youth. Therefore, they must be studied separately. Our population is particular because the majority of patients were soldiers and associate factors were related to their activities. And the hospitalization for erysipelas may affect their activities and training. Hence, it is important to identify favorable factors to prevent recurrence and other complications. There are also some limitations to this study. The retrospective design did not allow extracting risk factors. Only available information restricted to medical records was extracted. Factors are difficult to assess retrospectively such as obesity, foot dermatosis, alcoholism, and were probably underrepresented. A case-control study could further give a better level of evidence.

Conclusion

The results of this study confirm the major role of local factors as onychomycosis and plantar dyshidrosis eczema; and general factors as diabetes mellitus and female sex in the recurrence of erysipelas in the young population. This study has some limitations, the retrospective design of our study and the heterogeneity of the population. However, the originality of this study consists of identifying factors associated with recurrence in erysipelas in a young population.

Acknowledgements:

none Favorable factors with recurrence (n=6) Without recurrence (n=141) Odds Ratio IC 95% P value -sex (Male/Female) 3/3 124/17 7,29 1,36-39,08 0,033 -Diabetes mellitus 1 (16,7%) 1 (0,8%) 28 1,52-514,92 NS -BMI 30 Kg/m2 25 Kg/m2 7,33 24-26,8 NS -lymphedema 1 (16,7%) 4 (3,1%) 6,87 0,64-72,98 NS -venous insufficiency 1 (16,7%) 6 (4,3%) 4,5 0,45-44,7 NS -Alcoholism 1 (16,7%) 9 (6,9%) 2,71 0,28-25,75 NS -Local signs of severity 1 (25%) 6 (42,9%) 0,44 0,03-5,4 NS -Toe-web intretrigo 3 (50%) 63 (44,7%) 1,23 0,24-6,34 NS -Traumatic wound 0 30 (21,3%) NS -Cutaneous leishmaniasis 0 12 (8,5%) NS -Plantar dyshidrosis eczema 2 (33,3%) 4 (2,8%) 17,12 2,39-122,44 0,019 -Insect bite 0 7 (5%) NS -Onychomycosis 1 (16,7%) 2 (1,4%) 13,9 1,07-179,96 NS Percents are given in parentheses, NS: non significant Factors associated with of recurrent erysipelas P value Female 0,042 Plantar dyshidrosis eczema <10-3 Diabetes mellitus 0,002 Onychomycosis 0,004
  11 in total

1.  Risk factors for erysipelas of the leg (cellulitis): case-control study.

Authors:  A Dupuy; H Benchikhi; J C Roujeau; P Bernard; L Vaillant; O Chosidow; B Sassolas; J C Guillaume; J J Grob; S Bastuji-Garin
Journal:  BMJ       Date:  1999-06-12

2.  Risk factors for erysipelas of the leg in Tunisia: a multicenter case-control study.

Authors:  Mourad Mokni; Alain Dupuy; Mohamed Denguezli; Raouf Dhaoui; Samir Bouassida; Montacer Amri; Sami Fenniche; Faten Zeglaoui; Nejib Doss; Rafiaa Nouira; Amel Ben Osman-Dhahri; Jamel Zili; Insaf Mokhtar; Mohamed Ridha Kamoun; Abdelmajid Zahaf; Olivier Chosidow
Journal:  Dermatology       Date:  2006       Impact factor: 5.366

3.  Recurrent cellulitis: risk factors, etiology, pathogenesis and treatment.

Authors:  Maciej Piotr Chlebicki; Choon Chiat Oh
Journal:  Curr Infect Dis Rep       Date:  2014-09       Impact factor: 3.725

Review 4.  Erysipelas: recognition and management.

Authors:  Jean-Marie Bonnetblanc; Christophe Bédane
Journal:  Am J Clin Dermatol       Date:  2003       Impact factor: 7.403

5.  [Erysipelas in the young population of a military hospital].

Authors:  E Mahé; P Toussaint; D Lamarque; S Boutchnei; Y Guiguen
Journal:  Ann Dermatol Venereol       Date:  1999 Aug-Sep       Impact factor: 0.777

6.  Epidemiological data and comorbidities of 428 patients hospitalized with erysipelas.

Authors:  José Maria Pereira de Godoy; Patricia Galacini Massari; Mônica Yoshino Rosinha; Rafael Marinelli Brandão; André Luís Foroni Casas
Journal:  Angiology       Date:  2010-02-10       Impact factor: 3.619

7.  Factors predisposing to acute and recurrent bacterial non-necrotizing cellulitis in hospitalized patients: a prospective case-control study.

Authors:  M Karppelin; T Siljander; J Vuopio-Varkila; J Kere; H Huhtala; R Vuento; T Jussila; J Syrjänen
Journal:  Clin Microbiol Infect       Date:  2009-08-20       Impact factor: 8.067

8.  [Risk factors associated with leg erysipelas (cellulitis) in sub-Saharan Africa: A multicentre case-control study].

Authors:  P Pitché; B Diatta; O Faye; B-F Diané; A Sangaré; P Niamba; C Mandengue; L Kobengue; B Saka; A Diop; F Ly; M-T Dieng; A Dicko; M-M Soumah; M Cissé; S-H Kourouma; Y-I Kouassi; T Boukari; S Akakpo; K Tchangaï-Walla
Journal:  Ann Dermatol Venereol       Date:  2015-09-09       Impact factor: 0.777

9.  Comorbidities as Risk Factors for Acute and Recurrent Erysipelas.

Authors:  Vesna Brishkoska-Boshkovski; Irena Kondova-Topuzovska; Katerina Damevska; Andrej Petrov
Journal:  Open Access Maced J Med Sci       Date:  2019-03-15

10.  Recurrent erysipelas--risk factors and clinical presentation.

Authors:  Malin Inghammar; Magnus Rasmussen; Adam Linder
Journal:  BMC Infect Dis       Date:  2014-05-18       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.